Meet Inspiring Speakers and Experts at our 3000+ Global Conference Series Events with over 1000+ Conferences, 1000+ Symposiums
and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series : World's leading Event Organizer

Back

Dr. Harry S. Goldsmith

Dr. Harry S. Goldsmith

University of California, Davis United States

Title: Omental Transposition to the Brain for Alzheimer’s Disease

Biography

Biography: Dr. Harry S. Goldsmith

Abstract

It has been commonly believed that a decrease in cerebral blood flow (CBF) which routinely occurs in Alzheimer disease (AD) results from the death of critical intra-cerebral neurons that no longer require the maintenance of an adequate blood supply.  This belief is presently being challenged by the idea that it is not neuronal death that causes a decrease in CBF, but it is actually a decrease in the CBF which leads to the death of neurons seen in AD.  In association with dead neurons located within the AD brain are varying numbers of deteriorating neurons.  Increasing the CBF to still viable but deteriorating neurons in AD is believed to delay and even improve the clinical manifestations of AD. This increase in CBF has proven effective in treating a group of patients with AD.  The increase in CBF was accomplished surgically by placing an intact, vascularized pedicled omentum directly on the AD brain. This surgical procedure should be evaluated by a carefully controlled study since finding a treatment for Alzheimer’s disease is presently of extreme importance